Melanotan 2

Melanotan 2 is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH), engineered to activate melanocortin receptors and drive pigmentation responses in human skin with significantly greater potency and metabolic stability than its endogenous counterpart.

Mechanism & Pharmacology of Melanotan 2

Melanotan 2 (MT-2) operates primarily through agonism of the melanocortin 1 receptor (MC1R), which is expressed on the surface of melanocytes — the specialised pigment-producing cells distributed throughout the basal layer of the epidermis. When MT-2 binds the MC1R, it triggers a cyclic AMP-mediated signalling cascade that upregulates tyrosinase activity. Tyrosinase is the rate-limiting enzyme in melanogenesis, catalysing the conversion of L-tyrosine to DOPA and subsequently to dopaquinone, the precursor to eumelanin — the brown-black pigment responsible for darkening of skin and hair.

Beyond MC1R, Melanotan 2 also displays agonist activity at MC3R, MC4R, and MC5R. The MC4R interaction is particularly notable: MC4R signalling in the hypothalamus is associated with appetite regulation and energy homeostasis, and separately with pro-erectile responses mediated through spinal cord pathways. This broad receptor profile explains the range of physiological effects attributed to the peptide beyond simple pigmentation.

Structurally, MT-2 is a cyclic heptapeptide — Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂ — derived from the 13-amino-acid α-MSH sequence. The cyclisation and the incorporation of D-phenylalanine at position 7 dramatically improve its resistance to proteolytic degradation compared to linear α-MSH, extending its plasma half-life to approximately 1–2 hours following subcutaneous administration. Bioavailability via the subcutaneous route is considered high, with peptide distribution occurring systemically, allowing melanocytes throughout the body — not merely at the injection site — to respond to the stimulus.

The compound was originally developed at the University of Arizona in the late 1980s and early 1990s as part of a programme investigating synthetic melanotropins for potential therapeutic use in erythropoietic protoporphyria and other photodermatological conditions. Research-grade reconstitution typically involves bacteriostatic water, and the lyophilised powder form used in standard 10mg vials provides excellent shelf stability when stored correctly at 2–8°C prior to reconstitution.

Application Context & User Groups

Within the bodybuilding and physique sports community, Melanotan 2 is most commonly sought by individuals who aim to achieve a deeper, more even skin tone without relying exclusively on prolonged UV exposure. For competitors preparing for shows or photoshoots, a well-developed tan enhances the visual contrast between muscle groups and subcutaneous fat distribution, making striations, vascularity, and overall conditioning appear more pronounced under stage lighting. This is not a trivial consideration: under the intense directional lighting used in classic physique, men's physique, and bikini competitions, skin tone can substantially influence how judges and cameras perceive muscle separation.

MT-2 has also attracted interest from individuals with fair or Type I–II Fitzpatrick skin classifications who burn readily and tan poorly. For this demographic, natural UV-induced pigmentation is both inefficient and associated with accelerated photoageing and elevated erythema risk. Melanotan 2 primes melanocytes to produce eumelanin more readily in response to whatever UV input does occur, meaning lower cumulative UV exposure may be needed to achieve visible tanning — a pharmacological feature studied in the context of sun-protection research.

Beyond pigmentation, users in physique and general fitness contexts have reported ancillary effects consistent with the peptide's MC4R activity, including transient appetite suppression. This quality is occasionally considered a secondary advantage during calorie-restricted contest preparation phases, though individual response varies considerably and should not be treated as a primary use case.

Melanotan 2 is used by a diverse international demographic: competitive bodybuilders, recreational gym-goers pursuing aesthetic improvements, and photographic models seeking controlled pigmentation for seasonal work. The 10mg concentration per vial is the established standard in the research peptide sector, allowing flexible dosing protocols across a spectrum of body weights and individual sensitivity profiles. Users new to melanocortin peptides typically begin with conservative amounts to assess tolerance, given the receptor's broad central and peripheral distribution.

It should be noted that MT-2 remains a research compound and has not received regulatory approval as a licensed medicine in the UK or most international markets. Users should consult a qualified healthcare professional before use.

Range & Selection by Concentration and Pack Size

The Melanotan 2 category currently offers two products, both standardised at the industry-standard 10mg per vial and supplied as single-vial packs — the most practical format for individual use cycles and for those wishing to assess a manufacturer before committing to larger quantities.

MT-2 10mg/vial 1 Vial by Bio-Peptide represents the offering from Bio-Peptide, a manufacturer known within the research peptide sector for consistent lyophilisation quality and purity documentation. The 10mg vial format from Bio-Peptide suits users who prefer a well-established brand with a recognisable presence in European peptide markets.

Melanotan 2 10mg/vial 1 Vial by Knoll Pharmaceuticals provides the alternative option for those who prioritise sourcing from Knoll Pharmaceuticals, a manufacturer with its own quality processes and reputation for pharmaceutical-grade peptide production. Knoll's entry at the same 10mg concentration means users can compare manufacturers without any dosing recalculation.

For those new to Melanotan 2, the single-vial 10mg format from either manufacturer is the logical starting point — it allows a complete initial cycle without excess stock and provides a direct basis for comparison if you choose to alternate between brands thereafter. Experienced users familiar with their individual response to MT-2 may simply select based on manufacturer preference or availability. Both products in this category occupy the same concentration tier, so the selection decision reduces cleanly to brand trust, sourcing preference, and price point rather than any pharmacological difference between the offerings.

Frequently Asked Questions

How does Melanotan 2 differ from Melanotan 1?

Melanotan 1 (afamelanotide) is a linear peptide with high selectivity for MC1R, making it more pigmentation-specific. Melanotan 2 is a cyclic analogue with broader melanocortin receptor activity — including MC3R, MC4R, and MC5R — resulting in a wider physiological profile that extends beyond skin pigmentation alone. MT-2 also has a shorter half-life but is considered more potent on a per-milligram basis.

What concentration of Melanotan 2 is standard for research purposes?

The 10mg per vial format is the established standard across the research peptide market. It provides sufficient material for a meaningful assessment cycle and aligns with the lyophilised powder format that offers optimal stability during storage and shipping. Both Bio-Peptide and Knoll Pharmaceuticals supply MT-2 at this concentration.

Does Melanotan 2 require UV exposure to produce visible tanning?

Yes — MT-2 stimulates melanocytes to produce and distribute eumelanin, but some degree of UV exposure is generally required to activate the full pigmentation response. The peptide essentially primes melanocytes to respond more efficiently and rapidly to UV input, rather than producing pigmentation entirely independently of light exposure.